SB-736398

ID: ALA3988771

Chembl Id: CHEMBL3988771

PubChem CID: 86064662

Max Phase: Preclinical

Molecular Formula: C13H12N4

Molecular Weight: 224.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1c(-c2ccccn2)nc2cnccc21

Standard InChI:  InChI=1S/C13H12N4/c1-2-17-12-6-8-14-9-11(12)16-13(17)10-5-3-4-7-15-10/h3-9H,2H2,1H3

Standard InChI Key:  BCWGHJXSHITJPK-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

RPS6KA5 Tchem Ribosomal protein S6 kinase alpha 5 (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 224.27Molecular Weight (Monoisotopic): 224.1062AlogP: 2.51#Rotatable Bonds: 2
Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.07CX LogP: 1.82CX LogD: 1.81
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.67Np Likeness Score: -1.71

References

1. Simon Townson and Suzanne Gokool. GlaxoSmithKline Published Kinase Inhibitor Set 2 Onchocerca lienalis Screening Data,  [10.6019/CHEMBL3988181]
2. Mancini RS, Barden CJ, Weaver DF, Reed MA..  (2021)  Furazans in Medicinal Chemistry.,  64  (4.0): [PMID:33569941] [10.1021/acs.jmedchem.0c01901]